A new clinical study found that drinking a daily tomato-soy juice formulation reduced pro-inflammatory proteins in healthy obese adults over a four-week intervention period.
Researchers measured biomarkers associated with chronic inflammation linked to metabolic disease. The juice group showed declines compared with placebo recipients who consumed a neutral beverage.
Nutrition scientists said bioactive compounds in tomatoes and soy may interact synergistically to modulate immune signaling. The study size and duration limit broad conclusions about long-term disease prevention.
Dietitians emphasized whole-food diets over single-product interventions for sustainable health improvements. Food industry partners funded portions of the research, requiring transparent conflict disclosures in publications.
Follow-up trials may test whether inflammation reductions translate into improved insulin sensitivity or cardiovascular markers. Participants maintained caloric intake controls to isolate effects of the juice formulation.
A tomato-soy juice intervention reduced inflammatory proteins in obese adults over four weeks in a clinical study. Authors cautioned short duration and sample size limit conclusions about long-term metabolic benefits.
Dietitians said whole-food diets remain preferable to single-product interventions for sustainable metabolic health. The research team plans longer studies measuring insulin sensitivity after extended juice intake.
Institutional review boards must approve any follow-on studies before clinical expansion proceeds.
Peer review of the tomato-soy findings is expected before broader dietary recommendations emerge.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://medicalxpress.com/